Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion

Clive N. May, Ken Ishikawa, Li Wan, John Williams, R. Mark Wellard, Gaby S. Pell, Graeme D. Jackson, Rinaldo Bellomo

Research output: Contribution to journalArticleResearchpeer-review

29 Citations (Scopus)

Abstract

Purpose: To measure renal adenosine triphosphate (ATP) (bioenergetics) during hypotensive sepsis with or without angiotensin II (Ang II) infusion. Methods: In anaesthetised sheep implanted with a renal artery flow probe and a magnetic resonance coil around one kidney, we induced hypotensive sepsis with intravenous Escherichia coli injection. We measured mean arterial pressure (MAP), heart rate, renal blood flow RBF and renal ATP levels using magnetic resonance spectroscopy. After 2 h of sepsis, we randomly assigned sheep to receive an infusion of Ang II or vehicle intravenously and studied the effect of treatment on the same variables. Results: After E. coli administration, the experimental animals developed hypotensive sepsis (MAP from 92 ± 9 at baseline to 58 ± 4 mmHg at 4 h). Initially, RBF increased, then, after 4 h, it decreased below control levels (from 175 ± 28 at baseline to 138 ± 27 mL/min). Despite decreased RBF and hypotension, renal ATP was unchanged (total ATP to inorganic phosphate ratio from 0.69 ± 0.02 to 0.70 ± 0.02). Ang II infusion restored MAP but caused significant renal vasoconstriction. However, it induced no changes in renal ATP (total ATP to inorganic phosphate ratio from 0.79 ± 0.03 to 0.80 ± 0.02). Conclusions: During early hypotensive experimental Gram-negative sepsis, there was no evidence of renal bioenergetic failure despite decreased RBF. In this setting, the addition of a powerful renal vasoconstrictor does not lead to deterioration in renal bioenergetics.

Original languageEnglish
Pages (from-to)886-893
Number of pages8
JournalIntensive Care Medicine
Volume38
Issue number5
DOIs
Publication statusPublished - 1 May 2012
Externally publishedYes

Keywords

  • Acute kidney injury
  • Angiotensin II Magnetic resonance spectroscopy
  • Renal blood flow Septic shock

Cite this

May, Clive N. ; Ishikawa, Ken ; Wan, Li ; Williams, John ; Wellard, R. Mark ; Pell, Gaby S. ; Jackson, Graeme D. ; Bellomo, Rinaldo. / Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion. In: Intensive Care Medicine. 2012 ; Vol. 38, No. 5. pp. 886-893.
@article{65e09448249a481c963fe37867e35e65,
title = "Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion",
abstract = "Purpose: To measure renal adenosine triphosphate (ATP) (bioenergetics) during hypotensive sepsis with or without angiotensin II (Ang II) infusion. Methods: In anaesthetised sheep implanted with a renal artery flow probe and a magnetic resonance coil around one kidney, we induced hypotensive sepsis with intravenous Escherichia coli injection. We measured mean arterial pressure (MAP), heart rate, renal blood flow RBF and renal ATP levels using magnetic resonance spectroscopy. After 2 h of sepsis, we randomly assigned sheep to receive an infusion of Ang II or vehicle intravenously and studied the effect of treatment on the same variables. Results: After E. coli administration, the experimental animals developed hypotensive sepsis (MAP from 92 ± 9 at baseline to 58 ± 4 mmHg at 4 h). Initially, RBF increased, then, after 4 h, it decreased below control levels (from 175 ± 28 at baseline to 138 ± 27 mL/min). Despite decreased RBF and hypotension, renal ATP was unchanged (total ATP to inorganic phosphate ratio from 0.69 ± 0.02 to 0.70 ± 0.02). Ang II infusion restored MAP but caused significant renal vasoconstriction. However, it induced no changes in renal ATP (total ATP to inorganic phosphate ratio from 0.79 ± 0.03 to 0.80 ± 0.02). Conclusions: During early hypotensive experimental Gram-negative sepsis, there was no evidence of renal bioenergetic failure despite decreased RBF. In this setting, the addition of a powerful renal vasoconstrictor does not lead to deterioration in renal bioenergetics.",
keywords = "Acute kidney injury, Angiotensin II Magnetic resonance spectroscopy, Renal blood flow Septic shock",
author = "May, {Clive N.} and Ken Ishikawa and Li Wan and John Williams and Wellard, {R. Mark} and Pell, {Gaby S.} and Jackson, {Graeme D.} and Rinaldo Bellomo",
year = "2012",
month = "5",
day = "1",
doi = "10.1007/s00134-012-2487-2",
language = "English",
volume = "38",
pages = "886--893",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer-Verlag London Ltd.",
number = "5",

}

May, CN, Ishikawa, K, Wan, L, Williams, J, Wellard, RM, Pell, GS, Jackson, GD & Bellomo, R 2012, 'Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion', Intensive Care Medicine, vol. 38, no. 5, pp. 886-893. https://doi.org/10.1007/s00134-012-2487-2

Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion. / May, Clive N.; Ishikawa, Ken; Wan, Li; Williams, John; Wellard, R. Mark; Pell, Gaby S.; Jackson, Graeme D.; Bellomo, Rinaldo.

In: Intensive Care Medicine, Vol. 38, No. 5, 01.05.2012, p. 886-893.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion

AU - May, Clive N.

AU - Ishikawa, Ken

AU - Wan, Li

AU - Williams, John

AU - Wellard, R. Mark

AU - Pell, Gaby S.

AU - Jackson, Graeme D.

AU - Bellomo, Rinaldo

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Purpose: To measure renal adenosine triphosphate (ATP) (bioenergetics) during hypotensive sepsis with or without angiotensin II (Ang II) infusion. Methods: In anaesthetised sheep implanted with a renal artery flow probe and a magnetic resonance coil around one kidney, we induced hypotensive sepsis with intravenous Escherichia coli injection. We measured mean arterial pressure (MAP), heart rate, renal blood flow RBF and renal ATP levels using magnetic resonance spectroscopy. After 2 h of sepsis, we randomly assigned sheep to receive an infusion of Ang II or vehicle intravenously and studied the effect of treatment on the same variables. Results: After E. coli administration, the experimental animals developed hypotensive sepsis (MAP from 92 ± 9 at baseline to 58 ± 4 mmHg at 4 h). Initially, RBF increased, then, after 4 h, it decreased below control levels (from 175 ± 28 at baseline to 138 ± 27 mL/min). Despite decreased RBF and hypotension, renal ATP was unchanged (total ATP to inorganic phosphate ratio from 0.69 ± 0.02 to 0.70 ± 0.02). Ang II infusion restored MAP but caused significant renal vasoconstriction. However, it induced no changes in renal ATP (total ATP to inorganic phosphate ratio from 0.79 ± 0.03 to 0.80 ± 0.02). Conclusions: During early hypotensive experimental Gram-negative sepsis, there was no evidence of renal bioenergetic failure despite decreased RBF. In this setting, the addition of a powerful renal vasoconstrictor does not lead to deterioration in renal bioenergetics.

AB - Purpose: To measure renal adenosine triphosphate (ATP) (bioenergetics) during hypotensive sepsis with or without angiotensin II (Ang II) infusion. Methods: In anaesthetised sheep implanted with a renal artery flow probe and a magnetic resonance coil around one kidney, we induced hypotensive sepsis with intravenous Escherichia coli injection. We measured mean arterial pressure (MAP), heart rate, renal blood flow RBF and renal ATP levels using magnetic resonance spectroscopy. After 2 h of sepsis, we randomly assigned sheep to receive an infusion of Ang II or vehicle intravenously and studied the effect of treatment on the same variables. Results: After E. coli administration, the experimental animals developed hypotensive sepsis (MAP from 92 ± 9 at baseline to 58 ± 4 mmHg at 4 h). Initially, RBF increased, then, after 4 h, it decreased below control levels (from 175 ± 28 at baseline to 138 ± 27 mL/min). Despite decreased RBF and hypotension, renal ATP was unchanged (total ATP to inorganic phosphate ratio from 0.69 ± 0.02 to 0.70 ± 0.02). Ang II infusion restored MAP but caused significant renal vasoconstriction. However, it induced no changes in renal ATP (total ATP to inorganic phosphate ratio from 0.79 ± 0.03 to 0.80 ± 0.02). Conclusions: During early hypotensive experimental Gram-negative sepsis, there was no evidence of renal bioenergetic failure despite decreased RBF. In this setting, the addition of a powerful renal vasoconstrictor does not lead to deterioration in renal bioenergetics.

KW - Acute kidney injury

KW - Angiotensin II Magnetic resonance spectroscopy

KW - Renal blood flow Septic shock

UR - http://www.scopus.com/inward/record.url?scp=84862780230&partnerID=8YFLogxK

U2 - 10.1007/s00134-012-2487-2

DO - 10.1007/s00134-012-2487-2

M3 - Article

C2 - 22302028

AN - SCOPUS:84862780230

VL - 38

SP - 886

EP - 893

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 5

ER -